Journals / Adli Tıp Dergisi / 2014 / Cilt: 28 - Sayı: 2

Determination of the Organic Compounds in Synthetic Tablets Containing MDMA (Ecstasy)

MDMA (Ekstazi) İçeren Sentetik Tabletlerdeki Organik İçeriklerinin Belirlenmesi

Pages
164–177
Publication Date
2022-10-11
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

RESULTS: It was concluded that during synthesis of the MDMA, the best pH was 11 for occurring midproducts and coproducts, and the best solvent was found as diethyl ether which separated more analytes than the other organic solvents.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:OBJECTIVE: Determination of the organic compounds during the synthesis of MDMA in illicit ecstasy samples.
📊
Key Findings & Data:RESULTS: It was concluded that during synthesis of the MDMA, the best pH was 11 for occurring midproducts and coproducts, and the best solvent was found as diethyl ether which separated more analytes than the other organic solvents.
💡
Conclusion & Impact:As a result the production method of MDMA and the organic contents of ecstasy tablets were obtained by this study.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

OBJECTIVE: Determination of the organic compounds during the synthesis of MDMA in illicit ecstasy samples. METHODS: The samples used in this study were ecstasy tablets caught and delivered to Ankara Criminal Police Laboratory by Police Forces. Aqueous suspensions of sample tablets were extracted to clarify their organic contents with different solvents like chloroform, diethyl ether, dichloromethane, toluene, benzene and ethyl acetate at different PH s. The solutions of the tablets qualitative analysis were analyzed by GC-MS. RESULTS: It was concluded that during synthesis of the MDMA, the best pH was 11 for occurring midproducts and coproducts, and the best solvent was found as diethyl ether which separated more analytes than the other organic solvents. CONCLUSION: In this study, the molecular definition of occurring midproducts and coproducts during production of MDMA were determinated with using GC-MS. As a result the production method of MDMA and the organic contents of ecstasy tablets were obtained by this study.

Özet

AMAÇ: Ekstazi tabletlerindeki MDMAnın sentezi esnasında oluşan organik içeriklerinin belirlenmesidir. YÖNTEMLER: Bu çalışmada kullanılan örnekler, Polis tarafından yakalanarak Ankara Kriminal Polis Laboratuvarına getirilen Ekstazi tabletleridir. Organik içeriklerin belirlenmesinde tabletlerden alınan örneklerin sulu süspansiyonları kloroform, dietileter, diklorometan, toluen, benzen ve etil asetat gibi farklı çözücüler ile farklı pHlarda özütlenerek GC-MS ile nitel analizleri yapıldı. BULGULAR: MDMA sentezi sırasında oluşan ara ve yan bileşenler için en uygun pHnın 11 olduğu ve organik çözücülerden en uygun çözücünün ise en fazla bileşenin ayrılabildiği dietileter olduğu belirlendi. SONUÇ: MDMAnın sentezi sırasında kullanılan hammadde, oluşan ara ve yan ürünlerin GC-MS ile moleküler tanımlamaları yapıldı. Sonuç olarak, MDMAnın üretim yöntemi ve ekstazi tabletlerinin organik içeriğine ait bilgiler elde edilmiştir

🔖

Cite This Article

BORA, T., NURALIN, F., ŞENOCAK, N., AYDIN, H. (2022). Determination of the Organic Compounds in Synthetic Tablets Containing MDMA (Ecstasy). Adli Tıp Dergisi, Cilt: 28 - Sayı: 2, 164–177. https://ajindex.com/articles/428762

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Bora T. Yakalanan ekstazi tabletlerinin ni- tel, nicel ve kaynak belirlemesinde kullanı- lan analiz yöntemlerinin geliştirilmesi. Gazi Üniversitesi, Doktora Tezi, Ankara, 2007
  2. United Nations Office on Drugs and Crime (UNODC). World Drug Report 2005. Vienna, Austria: UNODC, 2005:39-103
  3. T.C. İçişleri Bakanlığı Emniyet Genel Müdürlüğü Kaçakçılık ve Organize Suçlarla Mücadele Daire Başkanlığı, 2005 Raporu. Emniyet Genel Müdürlüğü Kaçakçılık ve Organize Suçlarla Mücadele Daire Başkanlığı, Ankara, 2006:117-65
  4. Jansen KLR. Ecstasy (MDMA) dependence. Drug and Alcohol Depend 1999;53(2):121-4
  5. Ghysel MH. Amphétamines et dérivés. EMC-Toxicologie-Pathologie 2004;1(1):13- 20
  6. Tanç O, Biçer F, Ak N. Adli Tıp Kurumu Kimyasal Tahliller İhtisas Dairesi Narkotik Laboratuvarına 1999-2000 yıllarında İs- tanbul Adliyelerinden gönderilen ecstasy tabletlerinin profili. Yıllık Adli Tıp Toplan- tıları Sözlü Bildiriler, İstanbul: Adli Tıp Ku- rumu Yayınları, 2001;2:233-5
  7. Verebey K, Alrazi J, Jaffe JH. The complications of ‘ecstasy’ (MDMA). JAMA 1988;259(11):1649-50
  8. Gökçe E. Ecstacy Örneklerinin Bileşimle- rinin İncelenmesi ve Kaynakları Ortak Olan- ların Belirlenmesi, Yüksek Lisans Tezi, Gazi Üniversitesi, Fen Bilimleri Enstitüsü, Anka- ra, 2002;13-28
  9. Ecstasy: Des données biologiques et cliniques aux contextes d’usage. Rapport. Paris: Les Editions INSERM, 1997:9,88- 98,117-23,134
  10. The Merck Index, Merck Research Laboratories Division of Merck & Co, Inc., Twelfth Edition, New Jersey: Whitehouse Station, 1996;268-1384
  11. Gimeno P, Besacier F, Chaudron- Thozet, H, Girard J, Lamotte A. A contribution to the chemical profiling of 3,4 methylenedioxymethamphetamin (MDMA) tablets. Forensic Sci Int 2002;127(1-2):1- 44
  12. Jonson CSL, Artizzu N. Factors influencing the extraction of impurities from leuckart amphetamine. Forensic Sci Int 1998;93(2):99-116
  13. Maguire R. The development, validation and application of analytical methods for the analysis of drugs of abuse. University of Dublin, Trinity College, PhD thesis, 2001;80-186
  14. Gimeno P, Besacier F, Bottex M, Dujourdy L, Chaudron-Thozet, H. A study of impurities in intermediates and 3,4-methylenedioxymethamphetamin (MDMA) samples produced via reductive amination routes. Forensic Sci Int 2005;155(2-3):141-57. 15. Ś wist M, Wilamowski J, Parczewski A. Determination of synthesis method of ecstacy based on the basic impurities. Forensic Sci Int 2005;152(2-3):175-84. 16. Ś wist M, Wilamowski J, Parc